{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:43:29Z","timestamp":1793835809058,"version":"4.6.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10096-022-04504-6","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T03:05:17Z","timestamp":1665111917000},"page":"1399-1405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gastrointestinal colonization by OXA-48-producing Enterobacterales: risk factors for persistent carriage"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-840X","authenticated-orcid":false,"given":"O.","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Filgueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carmen","family":"Gonz\u00e1lez-Novoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Dom\u00ednguez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"\u00c1vila-Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Represa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rubi\u00f1\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mart\u00ednez-Lamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"P\u00e9rez-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rubianes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T.","family":"P\u00e9rez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"issue":"3","key":"4504_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL et al (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18(3):318\u201327. https:\/\/doi.org\/10.1016\/S1473-3099(17)30753-3","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"4504_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1128\/aac.48.1.15-22.2004","volume":"48","author":"L Poirel","year":"2004","unstructured":"Poirel L, H\u00e9ritier C, Tol\u00fcn V, Nordmann P (2004) Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48(1):15\u201322. https:\/\/doi.org\/10.1128\/aac.48.1.15-22.2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4504_CR3","doi-asserted-by":"publisher","first-page":"e0227139","DOI":"10.1371\/journal.pone.0227139","volume":"15","author":"S-B Miquel","year":"2020","unstructured":"Miquel S-B, Matthew K, Carlos C-A, Antonella A, Martina B, Achilleas G et al (2020) Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis. PLoS ONE 15(1):e0227139. https:\/\/doi.org\/10.1371\/journal.pone.0227139","journal-title":"PLoS ONE"},{"issue":"14","key":"4504_CR4","doi-asserted-by":"publisher","first-page":"e24880","DOI":"10.1097\/MD.0000000000024880","volume":"100","author":"OL Rodr\u00edguez","year":"2021","unstructured":"Rodr\u00edguez OL, Sousa A, P\u00e9rez-Rodr\u00edguez MT, Mart\u00ednez-Lamas L, Su\u00e1rez RL, Mart\u00ednez CT et al (2021) Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia. Medicine (Baltimore) 100(14):e24880. https:\/\/doi.org\/10.1097\/MD.0000000000024880","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"4504_CR5","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1093\/jac\/dky295","volume":"73","author":"A Sousa","year":"2018","unstructured":"Sousa A, P\u00e9rez-Rodr\u00edguez MT, Soto A, Rodr\u00edguez L, P\u00e9rez-Landeiro A, Mart\u00ednez-Lamas L et al (2018) Effectiveness of ceftazidime\/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother 73(11):3170\u20135. https:\/\/doi.org\/10.1093\/jac\/dky295","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"4504_CR6","doi-asserted-by":"publisher","first-page":"e0258420","DOI":"10.1128\/AAC.02584-20","volume":"65","author":"A Aung-Hein","year":"2021","unstructured":"Aung-Hein A, Kala K, Jocelyn K, Pei-Yun H, Brenda A, David L et al (2021) Epidemiology and transmission of carbapenemase-producing Enterobacteriaceae in a health care network of an acute-care hospital and its affiliated intermediate- and long-term-care facilities in Singapore. Antimicrob Agents Chemother 65(8):e0258420. https:\/\/doi.org\/10.1128\/AAC.02584-20","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"4504_CR7","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1093\/jac\/dkw272","volume":"71","author":"I Machuca","year":"2016","unstructured":"Machuca I, Guti\u00e9rrez-Guti\u00e9rrez B, P\u00e9rez Cort\u00e9s S, Gracia-Ahufinger I, Serrano J, Madrigal MD et al (2016) Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother 71(11):3242\u20139. https:\/\/doi.org\/10.1093\/jac\/dkw272","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"4504_CR8","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1128\/AAC.02283-13","volume":"58","author":"T Carlo","year":"2014","unstructured":"Carlo T, Francesco S, Sarah F, Enrico T, Fabio A, Alessandro L et al (2014) Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: relevance of concomitant systemic antibiotic therapy. Antimicrob Agents Chemother 58(4):1972\u20131976. https:\/\/doi.org\/10.1128\/AAC.02283-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"4504_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1469-0691.12427","volume":"20","author":"E Tacconelli","year":"2014","unstructured":"Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U et al (2014) ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 20(Suppl 1):1\u201355. https:\/\/doi.org\/10.1111\/1469-0691.12427","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"4504_CR10","volume-title":"Practical guidelines for infection control in health care facilities","author":"Pacific World Health Organization Regional Office for the Western","year":"2004","unstructured":"Pacific World Health Organization Regional Office for the Western (2004) Practical guidelines for infection control in health care facilities. WHO Regional Office for the Western Pacific, Manila"},{"issue":"12","key":"4504_CR11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/1469-0691.12747","volume":"20","author":"M Giannella","year":"2014","unstructured":"Giannella M, Trecarichi EM, De Rosa FG, Del Bono V, Bassetti M, Lewis RE et al (2014) Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 20(12):1357\u20131362. https:\/\/doi.org\/10.1111\/1469-0691.12747","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"2","key":"4504_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.anaerobe.2011.11.005","volume":"18","author":"M-U Rashid","year":"2012","unstructured":"Rashid M-U, Weintraub A, Nord CE (2012) Effect of new antimicrobial agents on the ecological balance of human microflora. Anaerobe 18(2):249\u201353. https:\/\/doi.org\/10.1016\/j.anaerobe.2011.11.005","journal-title":"Anaerobe"},{"issue":"Suppl 2","key":"4504_CR13","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1086\/504481","volume":"43","author":"CJ Donskey","year":"2006","unstructured":"Donskey CJ (2006) Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli. Clin Infect Dis Off Publ Infect Dis Soc Am 43(Suppl 2):S62-69. https:\/\/doi.org\/10.1086\/504481","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"4504_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jgar.2018.11.014","volume":"17","author":"M Bassetti","year":"2019","unstructured":"Bassetti M, Carannante N, Pallotto C, Righi E, Di Caprio G, Bernardo M et al (2019) KPC-producing Klebsiella pneumoniae gut decolonisation following ceftazidime\/avibactam-based combination therapy: a retrospective observational study. J Glob Antimicrob Resist 17:109\u201311. https:\/\/doi.org\/10.1016\/j.jgar.2018.11.014","journal-title":"J Glob Antimicrob Resist"},{"issue":"5","key":"4504_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"issue":"1","key":"4504_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/geront\/10.1_part_1.20","volume":"10","author":"S Katz","year":"1970","unstructured":"Katz S, Downs TD, Cash HR, Grotz RC (1970) Progress in development of the index of ADL. Gerontologist 10(1):20\u201330. https:\/\/doi.org\/10.1093\/geront\/10.1_part_1.20","journal-title":"Gerontologist"},{"issue":"10","key":"4504_CR17","doi-asserted-by":"publisher","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"137","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP et al (2002) Health care\u2013associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791\u20137. https:\/\/doi.org\/10.7326\/0003-4819-137-10-200211190-00007","journal-title":"Ann Intern Med"},{"issue":"4","key":"4504_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","volume":"28","author":"M Paul","year":"2022","unstructured":"Paul M, Carrara E, Retamar P, T\u00e4ngd\u00e9n T, Bitterman R, Bonomo RA et al (2022) European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect 28(4):521\u201347. https:\/\/doi.org\/10.1016\/j.cmi.2021.11.025","journal-title":"Clin Microbiol Infect"},{"key":"4504_CR19","unstructured":"EUCAST: clinical breakpoints and dosing of antibiotics. Available at https:\/\/www.eucast.org\/clinical_breakpoints\/. Accessed January 10, 2021, n.d."},{"issue":"2","key":"4504_CR20","doi-asserted-by":"publisher","first-page":"dlab079","DOI":"10.1093\/jacamr\/dlab079","volume":"3","author":"M Spencer-Sandino","year":"2021","unstructured":"Spencer-Sandino M, Riquelme-Neira R, Shropshire WC, Dinh AQ, Gonz\u00e1lez-Rocha G, Gonz\u00e1lez-Mu\u00f1oz P et al (2021) Selective digestive decontamination with oral colistin plus gentamicin for persistent bacteraemia caused by non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae in a neutropenic patient. JAC-Antimicrob Resist 3(2):dlab079. https:\/\/doi.org\/10.1093\/jacamr\/dlab079","journal-title":"JAC-Antimicrob Resist"},{"issue":"1","key":"4504_CR21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1128\/AAC.02021-13","volume":"58","author":"T Halaby","year":"2014","unstructured":"Halaby T, Al Naiemi N, Kluytmans J, van der Palen J, Vandenbroucke-Grauls CMJE (2014) Reply to \u201cColistin resistance during selective digestive tract decontamination is uncommon.\u201d Antimicrob Agents Chemother 58(1):627. https:\/\/doi.org\/10.1128\/AAC.02021-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"4504_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1473-3099(11)70067-6","volume":"11","author":"V Jean-Louis","year":"2011","unstructured":"Jean-Louis V, Fr\u00e9d\u00e9rique J (2011) Effect of selective decontamination on antibiotic resistance. Lancet Infect Dis 11(5):337\u2013338. https:\/\/doi.org\/10.1016\/S1473-3099(11)70067-6","journal-title":"Lancet Infect Dis"},{"key":"4504_CR23","unstructured":"Enlisting commensal microbes to resist antibiotic-resistant pathogens - PMC. Available at https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6314519\/. Accessed July 27, 2022, n.d."},{"key":"4504_CR24","doi-asserted-by":"publisher","unstructured":"Ghani R, Mullish BH, Roberts LA, Davies FJ, Marchesi JR (2022) The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases. Gut Microbes 14(1). https:\/\/doi.org\/10.1080\/19490976.2022.2038856","DOI":"10.1080\/19490976.2022.2038856"},{"key":"4504_CR25","doi-asserted-by":"publisher","unstructured":"Leo S, Lazarevic V, Girard M, Ga\u00efa N, Schrenzel J, de Lastours V, et al (2020) Metagenomic characterization of gut microbiota of carriers of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae following treatment with oral antibiotics and fecal microbiota transplantation: results from a multicenter randomized trial. Microorganisms 8(6). https:\/\/doi.org\/10.3390\/microorganisms8060941","DOI":"10.3390\/microorganisms8060941"},{"issue":"8","key":"4504_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/MCG.0000000000001281","volume":"54","author":"BK Perler","year":"2020","unstructured":"Perler BK, Chen B, Phelps E, Allegretti JR, Fischer M, Ganapini V et al (2020) Long-term efficacy and safety of fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection. J Clin Gastroenterol 54(8):701\u20136. https:\/\/doi.org\/10.1097\/MCG.0000000000001281","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"4504_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1473-3099(01)00066-4","volume":"1","author":"A Sullivan","year":"2001","unstructured":"Sullivan A, Edlund C, Nord CE (2001) Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 1(2):101\u2013114. https:\/\/doi.org\/10.1016\/S1473-3099(01)00066-4","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"4504_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijantimicag.2015.02.027","volume":"46","author":"M-U Rashid","year":"2015","unstructured":"Rashid M-U, Rosenborg S, Panagiotidis G, L\u00f6fdal KS, Weintraub A, Nord CE (2015) Ecological effect of ceftazidime\/avibactam on the normal human intestinal microbiota. Int J Antimicrob Agents 46(1):60\u20135. https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.02.027","journal-title":"Int J Antimicrob Agents"},{"key":"4504_CR29","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-Villodres \u00c1, Mart\u00edn-Gandul C, Pe\u00f1alva G, Guisado-Gil AB, Crespo-Rivas JC, Pach\u00f3n-Ib\u00e1\u00f1ez ME et al (2021) Prevalence and Risk Factors for Multidrug-Resistant\nOrganisms Colonization in Long-Term Care Facilities Around the World: A Review. Antibiotics 10(6):680. https:\/\/doi.org\/10.3390\/antibiotics10060680","DOI":"10.3390\/antibiotics10060680"},{"issue":"4","key":"4504_CR30","doi-asserted-by":"publisher","first-page":"E190","DOI":"10.1111\/1469-0691.12099","volume":"19","author":"N Feldman","year":"2013","unstructured":"Feldman N, Adler A, Molshatzki N, Navon-Venezia S, Khabra E, Cohen D et al (2013) Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 19(4):E190-196. https:\/\/doi.org\/10.1111\/1469-0691.12099","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"5","key":"4504_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1086\/659762","volume":"32","author":"S Vered","year":"2011","unstructured":"Vered S, Tali K, Jalal T, Meital K, David S, Shiri N-V et al (2011) Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol 32(5):497\u2013503. https:\/\/doi.org\/10.1086\/659762","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"4504_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1086\/661279","volume":"32","author":"B-D Debby","year":"2011","unstructured":"Debby B-D, Samira M, Shiri N-V, Hagit M, Ilan F, Bina R et al (2011) Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel. Infect Control Hosp Epidemiol 32(9):845\u2013853. https:\/\/doi.org\/10.1086\/661279","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"4504_CR33","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1086\/533475","volume":"46","author":"A Apisarnthanarak","year":"2008","unstructured":"Apisarnthanarak A, Bailey TC, Fraser VJ (2008) Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis Off Publ Infect Dis Soc Am 46(8):1322\u20133. https:\/\/doi.org\/10.1086\/533475","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"4504_CR34","doi-asserted-by":"publisher","unstructured":"Ramos-Ramos JC, L\u00e1zaro-Perona F, Arribas JR, Garc\u00eda-Rodr\u00edguez J, Mingorance J, Ruiz-Carrascoso G, et al (2020) Proof-of-concept trial of the combination of lactitol with Bifidobacterium bifidum and Lactobacillus acidophilus for the eradication of intestinal OXA-48-producing Enterobacteriaceae. Gut Pathog\u00a012. https:\/\/doi.org\/10.1186\/s13099-020-00354-9","DOI":"10.1186\/s13099-020-00354-9"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-022-04504-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-022-04504-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-022-04504-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T09:18:26Z","timestamp":1667467106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-022-04504-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4504"],"URL":"https:\/\/doi.org\/10.1007\/s10096-022-04504-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]},"assertion":[{"value":"5 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"When conducting the study, we followed the indications of the Declaration of Helsinki. The study was evaluated and approved by the regional ethics committee (2017\/336). STROBE recommendations were followed to ensure the reporting quality of the study. All the patients signed an informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}